Theranos Investor Conference Presentation Deck slide image

Theranos Investor Conference Presentation Deck

Collection and Activation 1 2 3 Blood drawn from lanced fingertip via capillary action Collection unit pressed into housing. Needles puncture through nanotainer caps, sliding plungers downward, like the action of a syringe. Specimen is drawn into each nanotainer (170 μL blood total) and simultaneously mixed with anti- coagulant (EDTA and/or Li-Hep) Nanotainer tubes removed for storage, transport, and processing. 2D barcode used to maintain traceability This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 62
View entire presentation